Genprex, Inc.
Research Genprex, Inc. (0A8I) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- Ticker0A8I
- ExchangeLSE
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
About Genprex, Inc.
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form.
Frequently asked questions
What does Genprex, Inc. do?
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes.